15 information-security-"https:"-"https:"-"https:"-"Dr" research jobs at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
Program
-
Field
-
are not limited to: natural language processing, large language models, graph learning, prompt engineering, knowledge graphs, knowledge engineering, linked data, web technologies. About the role
-
research environment that is open, welcoming and supportive to all. The faculty-wide initiatives are supported by an active Diversity & Inclusion Team. The Social, Genetic & Developmental Psychiatry (SGDP
-
20 Jan 2026 Job Information Organisation/Company KINGS COLLEGE LONDON Research Field Computer science Researcher Profile Recognised Researcher (R2) Established Researcher (R3) Application Deadline
-
, research & development, public health, or with people with lived experience. Understanding of data confidentiality and data security. Downloading a copy of our Job Description Full details of the role and
-
tools (e.g. NVivo, Excel, REDCap, SPSS). Knowledge of GDPR, the Data Protection Act, and best practices in data confidentiality and security. Ability to work collaboratively with multidisciplinary teams
-
disease (COPD), therapeutic dosing strategy to determine duration of action, (in house); pharmacokinetic (PK) data, and early safety profiles (maximum tolerated dose MTD) outsourced to Eurofins. This is a
-
, research & development, public health, or with people with lived experience. Understanding of data confidentiality and data security. Downloading a copy of our Job Description Full details of the role and
-
About Us The GSTT Asthma Service based at Guy’s Hospital is home to the largest cohort of severe asthma and EGPA patients receiving biologic therapies in the UK offering a unique opportunity to take
-
About us The post is based in the Centre for Society and Mental Health, a cross-Faculty initiative between the Faculty of Social Science and Public Policy (SSPP) and the Institute of Psychiatry
-
About Us The GSTT Asthma Service based at Guy’s Hospital is home to the largest cohort of severe asthma and EGPA patients receiving biologic therapies in the UK offering a unique opportunity to take